Company / SG&A per Share
Sonoma Pharmaceuticals, Inc. SG&A per Share History
FY2017-FY2026 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$4.50
FY2026
5-year range
$1.79 / $9.71
FY2022-FY2026
Trend
-53.6%
vs FY2025
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has fluctuated over the past 10 years, ranging from $1.79 in FY2024 to $29.05 in FY2019.
Based on SEC 10-K filings.
4.50 in FY2026 with a 5-year CAGR of -10.8%.
Increased from $1.79 to $4.50 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +12.7%
- 5-Year CAGR
- -10.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2026, sg&a per share decreased 53.6% year-over-year.
- Peak sg&a per share was recorded in FY2019.
- Lowest sg&a per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2026 | $4.50 | -53.6% |
| FY2025 | $9.71 | +441.7% |
| FY2024 | $1.79 | -43.0% |
| FY2023 | $3.15 | -30.4% |
| FY2022 | $4.52 | -43.4% |
| FY2021 | $7.97 | -43.6% |
| FY2020 | $14.15 | -51.3% |
| FY2019 | $29.05 | +630.2% |
| FY2018 | $3.98 | +7.3% |
| FY2017 | $3.71 | +349.2% |
As of FY2026 · SEC 10-K · Updated Jun 28, 2026